Traditionally, the prognosis of breast cancer has been known to be associated with tumor size, nodal status, hormonal receptor status, histologic grade, nuclear grade, human epidermal growth factor receptor 2 (HER2) expression, Ki-67 expression, etc. [21, 22]. This evidence concerns the gene NR4A1 and breast carcinoma.